Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection

Purpose Yttrium 90 (Y90) transarterial radioembolization (TARE) is effective for unresectable hepatocellular carcinoma (HCC) or to bridge/downstage before transplant; however, optimal patient selection is not well-described. This study aims to identify factors that increase risk of liver...

Full description

Bibliographic Details

Published in:	Journal of Clinical Interventional Radiology ISVIR
Main Authors:	Amelia Wong, Shirley Cheng, Anthony Herrera, Linda Wong
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2024-08-01
Subjects:	hepatocellular carcinoma yttrium 90 transarterial radioembolization
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1786711